MRK Merck & Co., Inc.

84.870.18 (+0.21%)
IEX real time price: 1:32:57 PM

Quote

Previous Close
$84.69
Day Range
$84.59-$85.09
52 Week Range
$66.10-$87.35
Volume
2,346,123
Avg Volume
8,154,771
Dividend TTM
$2.13 (2.52%)
Ex-Dividend Date
2019-09-13

Valuation

Market Cap
$217.30B
Enterprise Value (EV)
$233.09B
PE Ratio
23.59
EV/EBITDA
16.31
Price/Sales
5.11
Price/Book
8.12
PEG Ratio
1.04

Financials

Revenue
$42.45B
Gross Profit
$29.38B
EBITDA
$14.29B
EPS, ttm
$3.60
Profit Margin
14.65%
Revenue/Employee
$615.16K
Next Earnings Date
10/29/2019 (14 days)
Debt to Equity
94%
Debt
$24.65B
Cash
$8.86B
Net Debt
$15.79B

Performance

Beta
0.66
200 Day Moving Avg
$81.01
50 Day Moving Avg
$84.46
52 Week Change
21.93%
YTD Change
12.25%
1 Month Change
3.24%
3 Month Change
4.61%
6 Month Change
7.84%
1 Year Change
21.93%
2 Year Change
33.71%
5 Year Change
54.74%

Share Count

Shares Outstanding
2.6B
Float
2.6B
Restricted Shares
1.7M
Restricted Shares, %
0.07%

Merck & Co., Inc. Company Details

Sector: Health Technology

Industry: Pharmaceuticals: Major

CEO: Kenneth C. Frazier

Website: http://www.merck.com

Description: Merck & Co., Inc. engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, Healthcare Services, and Alliances. The Pharmaceutical segment includes human health pharmaceutical and vaccine products. The Animal Health segment discovers, develops, manufactures, and markets animal health products, such as pharmaceutical and vaccine products, for the prevention, treatment and control of disease in livestock and companion animal species, which it sells to veterinarians, distributors, and animal producers. The Healthcare Services segment offers services and solutions that focus on engagement, health analytics, and clinical services to improve the value of care delivered to patients. The Alliances segment includes results from the Company's relationship with AstraZeneca LP related to sales of Nexium and Prilosec. The company was founded in 1891 and is headquartered in Kenilworth, NJ.

Employees: 69,000